A previously unrecognized weakness in the immune defenses against certain blood neoplasms could offer a promising target for future treatments. Researchers have discovered that natural killer cells, which normally help the body eliminate malignant cells, remain remarkably active in patients with a particular genetic form of blood neoplasms. However, their ability to fight the disease appears to be restricted by an inhibitory molecular signal.
Continue to Phys.org →You are being forwarded in 6s — stay on this page